Simplex Trading
RCEL icon

Simplex Trading’s Avita Medical RCEL Stock Holding History

Simplex Trading’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,000
Closed -$10K – 9877
2025
Q2 		$10K Buy
2,000
+600
+43% +$4.37K ﹤0.01% 7331
2025
Q1 		$11K Buy
+1,400
New +$13.1K ﹤0.01% 7048
2024
Q4 		– Sell
-100
Closed -$1K – 9426
2024
Q3 		$1K Sell
100
-7,600
-99% -$71.4K ﹤0.01% 8256
2024
Q2 		$60K Buy
+7,700
New +$73.2K ﹤0.01% 5893
2024
Q1 		– Sell
-10,100
Closed -$138K – 9687
2023
Q4 		$138K Buy
10,100
+8,800
+677% +$101K ﹤0.01% 5055
2023
Q3 		$18K Sell
1,300
-11,000
-89% -$186K ﹤0.01% 6717
2023
Q2 		$209K Sell
12,300
-600
-5% -$8.8K ﹤0.01% 4250
2023
Q1 		$180K Buy
+12,900
New +$137K ﹤0.01% 4456
2021
Q2 		– Sell
-33
Closed -$65K – 10597
2021
Q1 		$65K Buy
33
+27
+450% +$628 ﹤0.01% 6300
2020
Q4 		$10K Buy
6
+1
+20% +$22 ﹤0.01% 7425
2020
Q3 		$12K Sell
5
-90
-95% -$2.24K ﹤0.01% 6712
2020
Q2 		$290K Buy
+95
New +$2.9K ﹤0.01% 3566

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Simplex Trading's RCEL Position: Q2 2026 in Review

Simplex Trading sold out of Avita Medical (RCEL) in Q2 2026, closing a stake of 4 shares — an estimated $17 sold.

Simplex Trading first reported a position in RCEL in Q2 2020 and held it in 16 quarters. The position peaked at $253K in Q2 2022. 74 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Simplex Trading reported no remaining Avita Medical position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 4 Avita Medical shares in Q2 2026, an estimated $17.
  • Simplex Trading first reported a position in Avita Medical in Q2 2020 and held it in 16 quarters.
  • Simplex Trading's Avita Medical position peaked at $253K in Q2 2022.
  • 74 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.